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To understand the regulation or the production of antimicrobial cationic pcptidc (CP) in Icukocytcs, cxprcssion of the CP gcnc was cvaluat& in 
vurious types ol’ Icukocytcs usinp guinea pig ncutrophils. monocytcs. macrophapcs. cosinophils. lymphocytes and bone marrow cells. Acid-urea 
PAGE and SDS-PAGE!immunoblot annlyscs showed that CP was prcscnt in ncutrophils ;Ind bone marrow cells. but not in other Icukocytcs. 
Norihcrn blot und transcription run-off anlrlyscs rcvcalcd that only bone marrow cclla exprcsscd CP mRNA and transcribed the CP gcnc. 
Intcrcrtingly. in situ hybridization :malysis using bone m;u’row cells dcmonstrarcd that CP mRNA WdS cxprcsscd in the ncutrophil precursor culls. 
such us promyclocyl.cs ;Ind n~yclocytcs, but wus not c!rixtcd in ~hc muturc ncutrophils and other bone marrow cells. Morcovcr. immunocyto- 
chemical study inilicated ~11;~ CP WIS prcscnt in the ncutrophil precursor cells and ~hc mature ncutrophils in the bone marrow. Thus, the CPgcnc 
appcilrs to bc cxprcsscd during u limircd period ol’ncutrophil maturation. and CP is likely synthcsizcd by the ncutrophil precursor cells in the bone 
murrow. 
C:honic pcphdc; Antimicrobiill psptidc: GCIX cxprcssion: III situ hybridization: Lcukocytc; Ginea pig 
I. INTRODUCTION 
Leukocytes play an important role in protecting hosts 
against microbial infection. Both oxidative and non- 
oxidative mechanisms arc used by leukocytes to restrict 
infection [l-3]. Molecules such as H,02, Oy and HOC1 
are examples of microbicidal agents that are derived 
from oxidative metabolism [1.3]. On the other hand, 
leukocytes contain antimicrobial components in the 
granules, which contribute to the oxygen-independent 
host defense mechanism [2,3]. Rcpresenlatives of these 
components are highly basic proteins and peptides, such 
as lysozyme, bactericidal/pernlcability-increasing pro-
tein (WI), cationic peptide (CP), major basic protein 
and eosinophil cationic protein [Z-9]. 
Lysozyme is distributed in the granules ofneutrophils 
and mononuclear phagocytes (rnonocytes and macro- 
phagcs), and is bactericidal for Gram-positive bacteria, 
but lacks activity against Gram-negative bacteria 
[2,3,5]. BP1 can be isolated from neutrophils, and dis- 
plays bacterir;idtil activity against Gram-negative bacte- 
cl(,hre~,ifrfit#ls: CP. cdtionic pcptidc: SDS-PAGE, sodium dodccyl sul- 
fate-polyacrylumide gel clcctrophorcsis: kDu, kilodaltons: kb kilo- 
bases. 
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ria but lacks activity against Gram-positive bacteria nd 
fungi [Z-5]. Major basic protein and eosinophil cationic 
protein are localized in the eosinophil gram&s. and are 
cytotoxic toward a range of parasites but exhibit mini- 
mal antibacterial ctivity [2,8.9]. In contrast. CP exhib- 
its a broad antimicrobial spectrum for Gram-positive 
and Gram-negative bacteria, fungi and viruses [Z-7]. In 
addition, CP expresses cytotoxic activity toward tumor 
cells [2,3,5,6]. CP has been isolated from humdn. rabbit, 
rat and guinea pig ncutrophils [7,10]. However, it is not 
known whcthcr leukocytes other than neutrophils are 
capable of producing CP. In this study, therefore, to 
understand the regulation of CP production in lcuko- 
cytes, we have evaluated the CP gene expression in var- 
ious types of leukocytes using guinea pig neutrophils, 
monocytes. macrophages, eosinophils. lymphocytes 
and bone marrow cells. 
2. MATERIALS AND METHODS 
Ciuinw pig ncutrophils. ly!‘lphocytcs. nronocytcs. peritoneal macro- 
phagcs. alveolar macrophagcs and cosinaphils were prepared as dc- 
scribed previously [I I. 121. The purity of the cells examined by Wright- 
Gicmsu stain was r908. Bone marrow cells were obtained from 
guincn pig femoral bones. 
2.2. Pvlwc.r’h~rttid~~ _gd &crrophore.si~s urrd itnrrttuahlof uttu!wis 
The &Is kcrc suspcndcd in 0.3-I iv1 su~rosc, and distruptcd in ice 
by sonication (four IO s bursts at 25 W). The s&cation was ccntri- 
fugcd II 100 g for IO min to jedimcnt the nuclei. and the supcrnalanl 
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(the post-n&x fraction) was analyzed by xidsureu PAGE (7.5% 
polyocryl;miidc. 6,25 M urcu) [ 13,141 end SDS-PAGE with a 7.5-l 5% 
linear yradicnt ol’ polyacrylamidc [I 51, The gel was silver-stained [ 161 
using a commercially uvailoblc rcagcnt kit (Diliiichi Pure Cbcmicals). 
In some experiments, after SDS-PAGE the proteins were clectro- 
phorulically lransfcrred LO a nitrocellulosc membrane (Schlcicher d 
Schuell). The membrilnc was incubated with Block Ace (Dainippon 
Pharmnccutical Co.) and reacted whh 1 I : I.000 dilution of a rabbit 
;mti-CP serum which had been prepared against purified guinea pig 
nrutrophil CP [IO] conjugated to ovalbumin [ 171. The proteins were 
detrctcd by incubation wilh u I :2.000 dilution of horserddish pcroxi- 
dascJabrlcd goat anti-rabbit IgG (Orgxxn Tckniku) followed by 
dcvelopmcnt with diformazan using the POD Immunoslain Se1 (Wake 
Pure Chemical Industries), Protein conccmruiions were mctisured by 
the method of Lowry et al. [IS]. 
Expression of CP mRNA was cvalualcd by Northern blot unalysis. 
Tolal cellular RNA isolated by the guanidinium thiocyam1te exirx- 
don method [ 191 was clcc~ropborcscd on ;I formaldehyde-containing 
ugilrosc gel. RNA was blotled onto a nylon membrane (Hybond-N. 
Amcrsham). and hybridized with CP cDNA probe [20] or y-actin 
cDNA probe (pHFyA-I [2l]) (gruciously provided by D. Gunningand 
L. Kedes. Stanford University) labeled with [“?P]dCTP (3,000 Gil 
~nmol. Amcrsham) by the random hcxanuclcoiidc primer mcihod [22]. 
The lranscriptlon of Abe CP gem was cvolualcd by a transcription 
‘run-off iIssi1y. as described previously [20], Nuclei isolated from the 
cells wcrc incubated with [“?P]UTP (800 Ci/mmol. hmersbam) to label 
nuclear RNA. Trunscriplion of the CP gene :md. us a comrol. the 
y-aclin gcnc. was determined by hybridization (40 h. 42°C) of the 
“‘P&beled nuclear RNA (IO’ cpm) to the filler-bound (nylon mem- 
brunt, Amcrsham; dot-blot apparatus. Bio-Rad ~dboratorics). unlu- 
bclcd cDNA targets (CP cDN.4 and y.actin EDNA) in the presence 
of 50% formamide and 10% dextran sulh~c. 
In situ hybridizittion was performed us dcscribcd previously [23] 
with minor modifications [24]. Cytoccntrifuge preparations (IO’ cells/ 
slide) were prepared nsing ti Cytospin 2 (340 rpm. IO min, Shundon 
Instruments) and siliconiecd RNAse-free gluss slides, The slides were 
fixed in 4% paraformaldchyde and then trciiied with 0.25% acetic 
unhydridc in 0.1 M triethunolamine buffer (pH 8.0) 10 reduce the 
non-specific binding of the probe. The slides wcrc then treated with 
proteinuse K and hybridized (IA-16 b. 50°C) with the ‘sS-k1bcled 
antisense CP cRNA probe (IO’ cpm/ml) in the presence of 50% forma- 
mide and 10% dcxtran sulfate. After RNAse treatment, the slides were 
dipped in Konicd NR-M2 emulsion, dried. cxposcd for 3 days at 4°C. 
developed in a Konica-Konidor dcvelopcr. and fixed in Fuji Fix. The 
cells were then stained with May-Grllnwald-Gicmsu to dcmonslralc 
nuclear morphology, To gcncrare ‘$S-labeled single-stranded cRNA 
probe, the CP cDNA was subcloncd into the transcription vector 
Bluescrip SK/- (Promcga) [20], and the lab&d CP ;1ntiscnse and 
sense cRNA probes were synthesized by transcription of ihe cDNA 
using pSS]UTP (800 Cilmmol, Amcrsham). When J’S-labclcd CP scnsc 
cRNA probe was used as a negative control no silver grain was 
observed in the cells examined (not shown). 
The cyiocentrifugc preparations were immunostainecl for CP, as 
described previously [25]. To inactivale the endogcnous pcroxidasc 
activity. the slides were m.?atcd with 0.1 M periodic acid and 0.02% 
sodium borohydride. The slides were then washed, and incubalcd in 
a I: 1.000 dilution of the rabbit anti-CP serum (described above). The 
slides were exrensively washed, and tbcn incuhiltcd in a I :2,000 dilu- 
lion of pcroxidasc-labeled goat anti-rabbit IgG (Organon Tcknika). 
After exrcnsive washing, the slides were devclopcd in 0.05% 3,3’- 
diaminobcrr;c’idinc/O.U1% hydrogen peroxide. The cells wcrc then 
counterstained with Muy-Grllnwald-Giemsu, 
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The two CPs with i1 diffcrcncc of only one amino acid residue [IO] 
und Ihc corresponding cDNAs with >99% homology [?O] have been 
already isoluted by us. Wbcn the CII’CCIS ol’ ihc two umisera or two 
cDNAs (corresponding to euch CP) wcrc examined, no difference was 
observed belwcen the two (not shown). 
3, RESULTS AND DISCUWON 
3.1. Evahru~ion qf rlre ceils cotttcthhg CP attd CP 
To evaluate the regulation of CP production in Icuko- 
cytes, the presence of CP in various types of leukocytes 
was first examined by electrophoretic snalysis. Acid- 
urea PAGE analysis showed the characteristic CP 
bands [IO] in mature neutrophils and bone marrow 
cells; the band was not detected in lymphocytes, perito- 
neal macrophages and eosinophils (Fig. IA). SDS- 
PAGE and immunoblot analysis also demonstrated 
that the 3.8”kDa bands corresponding to CP were da- 
tected in mature neutrophils and bone marrow cells, but 
not in other types of leukocytes (Fig. IB and C). The 
CP band was not detected in monocytes and alveolar 
macrophages by acid-urea PAGE and SDS-PAGE/im- 
munoblot analyses (not shown). 
Next, the expression of CP mRNA or the transcrip- 
tion of the CP gene was examined. Northern blot analy- 
sis revealed that bone marrow cells expressed the 
0.6-kb CP rnRNA transcript, whereas no CP mRNA 
transcript was observed in mature neutrophiis, lympho- 
cytes, peritoneal macrophages and eosinophils (Fig. 
2A). In contrast, when the same RNA samples were 
analyzed with a y-actin cDNA probe, the 2.2-kb y-actin 
mRNA transcripts were observed in these cells. Consis- 
tent with the results of Northern blot analysis, the tran- 
scription run-off assay demonstrated that the CP gene 
was transcribed in bone marrow cells but not in other 
types of leukocytes, although the y-actin gene was tran- 
scribed in these cells (Fig, 2B). The expression of CP 
mRNA and the transcription of the CP gene was not 
observed in monocytes and alveolar macrophages (not 
shown). Thus, among various types of leukocytes exam- 
ined, mature neutrophils and bone marrow cells con- 
tained CP, whereas only bone marrow cells transcribed 
the CP gene and expressed CP mRNA transcripts. 
3.2. IdmiJiccttiott of botw ttturro\v ccl/s qmssittg CP 
tttRNA 
Bone marrow cells are composed of various type of 
cells. Then, the bone marrow cells expressing CP 
mRNA transcripts were identified with in situ hybridi- 
zation using ‘%-labeled antisense CP cRNA probe. All 
the cells expressing CP mRNA belonged to the neutro- 
phi1 precursor cells (Fig. 3A-D). In this regard, meylo- 
biasts, promyelocytes, myelocytes and metamyelocytes 
were observed to express CP mRNA nratiscripts. while 
mature neutrophils did not express CP mRNA tran- 
scripts. CP mRNA was not detected in the cells of eo- 
sinophil, lymphocyte, monocyte and erythroid lineages 
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Fig. 1. Acid-urea PAGE and SDS-PAGYimmunoblot analyses of the cell extracts. The postnuclcar Tractions of various types of leukocytes were 
subjected to (A) acid-urea PAGE or (B) SDS-PAGE followed by (C) immunoblot analysis. Lane I, purified ncutrophil CP: lane 2. ncutrophils: 
Iant 3. bone marrow cells; lane 4. lymphocytes: lane 5. pcritoncal macrophages; lane 6. eosinophils. 3 ~16 of purified CP and IS-25 j!g of the 
post-nuclear I’ractions were analyzed by acid-urea PAGE, whcrcas 500 ng of purified CP and 5-8 ~6 or the post-nuclear fractions wcrc analyzed 
by SDS-DAGE/immunoblot analysis. Molccuklr weight standards: myosin (200 kDa). phosphorylasc h (92.5 kDa). bovine strum albumin (69 kDa). 
ovaibumin (46 kDu). carbonic anhydrasc (30 kDd), trypsin inhibitor (2i.5 kDa). lysozymc (14.3 kDd). myoglobin I (8.2 kDa) and myoglobin III 
(2.6 kDa). The arrows indicate the bands corresponding to CP. 
(not shown). Next. the cells containing CP mRNA were 
quantitated at different cell stages (Fig. 4). CP mRNA 
was detected to a limited extent in myeloblasts. Intercst- 
ingly, the percentage of the CP mRNA-positive cells 
increased markedly in the promyelocyte and myelocyte 
stages (>90%). However, the levels of the positive cells 
remarkably decreased thereafter. 
Furthermore. the bone marrow cells containing CP 
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Fig. 2. Evnluztior. of the expression or CP mRP:A and the transcription of CP gene. (A) Northern blot analysis ofCP mRNA. Total cellular RNA 
(IO yg) aT various types of leukocytes was electrophorcscd on an agarosc gel, and bloued onto a nylon mcmbranc. The blot was hybrid&l to 
3zP-labcled CP or y-xtin cDNA probe. The 0,6-kb CP mRKA and the 2.2-kb y-actin mRNA transcripts are indicalcd. (D) Transcription run-off 
analysis oT CP gene. Nuclei isolated from the cells were labeled with pzP]UTP, and the labeled nuclear RNA was hybridized to filter-bound CP 
(top) and pactin (bottom) cDNA targets. 
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Fig, 3. Evaluation of CP mRNA by in situ hybridization and imntunocytochemicul shiny ofCP. (A-D) Examples of bone marrow cells exhibiting 
CP mRNA transcripts. Bone milfrow cells were hybridized with ?S-labeled CP untisensc cRNA probe, end CP mRNA transcripts were dctccted. 
Myelobltist (MB), promyelocyle (PM), myelocytes (MC) and melamyclocytc (MM) show positive: hybridizoiion exhibiting silver grains. Mature 
netitrophils (PMN) arc ncgutiue. (E-H) Examples or bone marrow cells cont:lining CP. CP or the bone nurrow cells wus imn~unocytocl~emicnlly 
evaluated using the rabbit anti-CP serum and pcroxidac-labclcd anti-rabbit a&body. MB. PM. MC. MM and PMN urL’ stained and positive. 
Mugnifictition x500. 
were immunocytochemically evaluated using the anti- 
CP serum. CP was detected in the cells of neutrophil 
lineage such as myeloblasts, promyelocytes. myelocytes, 
metamyelocytes and mature neutrophils (Fig. 3E-H). 
On the other hand, CP was not detected in the cells of 
other cell lineages (not shown). When the CP-positive 
cells were quantified at different cell stages, a small 
percentage of myeloblasts was observed to possess CP 
(Fig. 4). Interestingly, the percentage of the CP-positive 
cells incrcnsed markedly a? the promyclocytc and my- 
elocyte stages (>90%) in parallel with the increase of CP 
mRNA. The increased levels of the positive cells re- 
mained almost constant after the myelocyte stage, al- 
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though the expression of CP mRNA was remarkably 
reduced. 
Together these observations suggest hat the CP gene 
is expressed uring a limited stage of neutrophil ineage 
maturation, and CP is likely synthesized by the neutro- 
phi1 precursor cells in the bone marrow and stored in 
the cells after synthesis. 
It is known that mature neutrophils do not express 
the mRNA transcripts for neutrophil elastase and my- 
clopcroxidasc, although they have thcsc proteins in the 
granules [26-291. A recent study using in situ hybridiza- 
tion has revealed that neutrophil elastase and myelo- 
peroxidase mRNA transcripts arc expressed only in the 
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Fig. 4. Proporlions or bone marrow cells wilhin each cell rtayc exhibiting CP mRNA lrsnscripls and CP. After the hybridizulion with “‘S-labeled 
uniiscnsc CP cRNA probe or the treulmcnl with ami-CP strum. the number ol‘posi~ivc cells l’or CP mRNA (0) and CP (m) within each stage was 
cvuluulcd. and expressed as u pcrccnl;lge 01. lhc total number ol’cclls in euch slagc. Euch dotu point rcprcscnts ~hc mean f SD. of at Icasl four 
cxpcrinicms. 
ncutrophil precursor cells in the bone marrow [30], sug- 
gesting that the synthesis of these granule proteins oc- 
curs during a p&cd ef neutrophil maturation that takes 
place in the bone marrow. The present study has shown 
that CP mRNA is also expressed in the neutrophil pre- 
cursor cells in the bone marrow, but not in the mature 
neutrophils. Thus, CP, one of the major antimicrobial 
components, also seems to be synthesized by the matur- 
ing neutrophils in the bone marrow, as are neutrophil 
elastase and myeloperoxidase. 
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